Saudi Arabia vs Western Pacific (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Saudi Arabia
99.0%
in 2025
Western Pacific (WHO region)
86.0%
in 2025
Saudi Arabia rank
1st
Western Pacific (WHO region) rank
4th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Saudi Arabia
- Western Pacific (WHO region)
How they compare
Saudi Arabia currently reports 99.0% against 86.0% in Western Pacific (WHO region), a difference of 13.0%.
That makes Saudi Arabia's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Western Pacific (WHO region) ahead.
Saudi Arabia ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.4% | 37.8% | 49.6% | Saudi Arabia |
| 2010s | 97.1% | 86.7% | 10.4% | Saudi Arabia |
| 2020s | 97.0% | 86.7% | 10.3% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Saudi Arabia or Western Pacific (WHO region)?
- Saudi Arabia, at 99.0% against 86.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Saudi Arabia and Western Pacific (WHO region)?
- 13.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Western Pacific (WHO region)?
- 26 years are reported by both, from 2000 to 2025.
- How do Saudi Arabia and Western Pacific (WHO region) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Saudi Arabia ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.